• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » House delays vote on Trumpcare bill

House delays vote on Trumpcare bill

March 23, 2017 By Fink Densford

The US House of Representatives today indefinitely delayed its vote on the Trumpcare legislation, which looks to begin dismantling Obamacare and replacing it with a GOP-supported framework.

The Trump administration and the GOP had hoped the day would signal a significant turn for conservatives, with Trump and House Republican leaders planning the vote on the 7th anniversary of former President Barack Obama signing his name to the Affordable Care Act, which became known as Obamacare.

Sen. Majority leader Mitch McConnel (R-Ky.) informed senators that a vote on the bill may not be held in the House before Monday, according to a senior Senate aide.

Last week, the Trumpcare bill won approval from the US House of Representatives Budget Committee, despite losing support from 3 conservatives.

The plan cleared the Committee with a 19 to 17 vote, with David Brat (R-Va), Gary Palmer (R-Al) and Mark Sanford (R-S.C.) voting against, joined by the panel’s Democrats.

The legislation was approved by the Energy & Commerce Committee and the Ways and Means committee a week prior.

Last week, the nonpartisan Congressional Budget Office released data on the effects of the Trumpcare bill, estimating it would cause 14 million individuals to lose healthcare next year, with 24 million losing coverage by 2026. The bill would also cut $337 billion from the federal budget deficits over 9 years, the CBO said.

Average premiums for individuals buying insurance on their own would increase 15% to 20% in 2018 and 2019 compared to the current ACA law, according to the budget office, but would be lower by approximately 10% by 2026.

The plan would also immediately remove the penalty for people who do not have health insurance and halt the expansion of Medicaid at the beginning of 2020, capping funding for the federal healthcare program for the poor. It would preserve a pair of popular Obamacare features: Allowing children to remain on family health plans until age 26 and barring insurers from denying coverage for pre-existing conditions.

The newly inked plan would abolish subsidies for purchasing healthcare, instead creating age-based tax credits that could be used to buy health insurance; the credits would be capped for people with higher incomes. And it would direct $100 billion to the states for programs aimed at certain populations, such as high-risk pools of the sickest patients.

While US House Speaker Paul Ryan said he believes there exists enough support to pass the bill, while others, such as Senator Roy Blunt, seem to doubt the bill’s ability to clear both the House and Senate.

“I’m going to be very anxious to hear how we get 51 votes and how the House gets 218,” Blunt told reporters.

The American Medical Association also came out against the bill, calling it “Critically Flawed”.

In a letter to congress, the AMA said it outlined provisions in the new bill that would have an adverse impact on patients and the health of the nation, which would be caused due to a large decline in health insurance coverage.

Material from Reuters was used in this report.

Filed Under: Healthcare Reform, Legal News Tagged With: Capitol Hill

More recent news

  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold
  • FDA clears Solventum’s combo wound care platform following Acera acquisition
  • GE HealthCare begins new global partnerships to advance theranostic imaging technology
  • Siemens Healthineers, Nvidia launch radiotherapy AI collaboration
  • J&J, Medtronic present pulsed field ablation data from global real-world use

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy